- Home
- GHG vs LXEO Comparison
GHG vs LXEO Comparison
Compare GHG & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- LXEO
- Stock Information
- Founded
- GHG 2004
- LXEO 2017
- Country
- GHG China
- LXEO United States
- Employees
- GHG N/A
- LXEO N/A
- Industry
- GHG Hotels/Resorts
- LXEO
- Sector
- GHG Consumer Discretionary
- LXEO
- Exchange
- GHG Nasdaq
- LXEO Nasdaq
- Market Cap
- GHG 289.4M
- LXEO 314.1M
- IPO Year
- GHG 2018
- LXEO 2023
- Fundamental
- Price
- GHG $2.70
- LXEO $7.57
- Analyst Decision
- GHG
- LXEO Strong Buy
- Analyst Count
- GHG 0
- LXEO 5
- Target Price
- GHG N/A
- LXEO $23.80
- AVG Volume (30 Days)
- GHG 5.0K
- LXEO 567.8K
- Earning Date
- GHG 11-21-2024
- LXEO 11-13-2024
- Dividend Yield
- GHG 3.62%
- LXEO N/A
- EPS Growth
- GHG N/A
- LXEO N/A
- EPS
- GHG 0.28
- LXEO N/A
- Revenue
- GHG $201,166,731.00
- LXEO N/A
- Revenue This Year
- GHG N/A
- LXEO N/A
- Revenue Next Year
- GHG $8.78
- LXEO N/A
- P/E Ratio
- GHG $9.60
- LXEO N/A
- Revenue Growth
- GHG N/A
- LXEO N/A
- 52 Week Low
- GHG $2.31
- LXEO $5.77
- 52 Week High
- GHG $4.10
- LXEO $22.33
- Technical
- Relative Strength Index (RSI)
- GHG 49.44
- LXEO 50.12
- Support Level
- GHG $2.66
- LXEO $5.77
- Resistance Level
- GHG $2.84
- LXEO $8.74
- Average True Range (ATR)
- GHG 0.09
- LXEO 0.90
- MACD
- GHG 0.01
- LXEO 0.23
- Stochastic Oscillator
- GHG 66.82
- LXEO 34.20
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.